NCT Number: NCT02836093
Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation Treatment
Many patients receiving radiation therapy for breast cancer experience fatigue although doctors do not fully understand why. The purpose of this study is to test if patients who experience fatigue during radiation treatment for breast cancer have changes in their capability to perform exercise on a treadmill.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–80 year
Sex eligibility
Female
Study type
Observational
Primary location
Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge, New Jersey, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Female
- ECOG performance status 0 or 1
- Medical clearance from attending radiation oncologist or medical oncologist to undergo a symptom-limited CPET
- Currently undergoing intact breast radiotherapy for early stage breast cancer (including TisN0, T1N0, T2N0) or has completed intact breast RT in the last 3 months.
- Receiving or received a prescribed dose of 4240 cGy in 16 fractions to the whole breast without treatment directed at nodal basins. Patients may also be receiving or have received a boost to the lumpectomy bed at the discretion of the treating physician.
- Subjects may be treated in the supine or prone position at the discretion of the treating physician.
- Subjects may be treated with or without a deep inspiratory breath hold technique at the discretion of the treating physician.
- Identified by the treating radiation oncologist as having significant treatment-related fatigue or minimal treatment-related fatigue and not simply baseline fatigue. A score of "0" on the RTOG fatigue scale will be considered minimal fatigue, while a score of "2" or greater will be considered significant fatigue (moderate fatigue causing difficulty performing some ADLs).
Exclusion criteria
- Currently undergoing post-mastectomy radiation
- Has received chemotherapy previously or has a plan to receive chemotherapy during the timeframe of study assessment.
- Any of the following absolute contraindications to CPET, as per American Thoracic Society (ATS) recommendations
- Acute myocardial infarction (within 3-5 days of any planned study procedures)
- Unstable angina
- Uncontrolled arrhythmia causing symptoms or hemodynamic compromise
- Recurrent syncope
- Active endocarditis
- Acute myocarditis or pericarditis
- Symptomatic severe aortic stenosis
- Uncontrolled heart failure
- Acute pulmonary embolus or pulmonary infarction within 3 months of any planned study procedures
- Thrombosis of lower extremities
- Suspected dissecting aneurysm
- Uncontrolled asthma
- Pulmonary edema
- Room air desaturation at rest ≤ 85%
- Respiratory failure
- Acute non-cardiopulmonary disorders that may affect exercise performance or be aggravated by exercise (i.e. infection, renal failure, thyrotoxicosis)
- Mental impairment leading to inability to cooperate
Treatment and study plan
Primary outcomes
-
fatigue measurement using the 13-item FACIT-fatigue scale
Time frame: 1 year
Fatigue will be assessed using the 13-item FACIT-fatigue scale for the assessment of fatigue in cancer patients.24 The FACIT-Fatigue is a validated questionnaire that was originally developed for the precise evaluation of fatigue levels in cancer patients with anemia. It consists of 13 questions using a 5 point scale (0=not at all; 1 = a little bit, 2 = somewhat, 3 = quite a bit and 4 = very much). It has been used frequently in the clinical trial setting (please see appendix 1). Responses to each question are added with equal weight to obtain a total score. The range of possible scores is 0-52, with 0 corresponding to the highest level of fatigue and 52 corresponding to the lowest level of fatigue.
Sponsors and collaborators
Lead sponsor
Memorial Sloan Kettering Cancer Center
Other
Registry information
Official study title
Pilot Study for Assessment of Exercise Capacity in Breast Cancer Patients With Radiotherapy-Related Fatigue
Important dates
- Study start
- 2016
- Primary completion
- 2023
- Study completion
- 2023
- First posted
- Jul 18, 2016
- Registry last updated
- Dec 29, 2023
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Reducing Sedentary Behaviour With Technology
NCT02911649
Behavior, Breast Cancer
Toronto, Ontario, Canada
View Trial DetailsTrial of a Behavior Change Intervention to Increase Aerobic and Resistance Exercise and Quality of Life in Older Prostate and Breast Cancer Survivors
NCT02321358
Behavior, Breast Cancer
St. John's, Newfoundland and Labrador, Canada
View Trial DetailsCombined Strength Training and Functional Endurance Exercise Regimen on Cancer -Related Fatigue and Physical Performance
NCT00421057
Behavior, Breast Cancer
Houston, Texas, United States
View Trial DetailsGut Microbe Composition, Exercise, and Breast Breast Cancer Survivors
NCT04088708
Behavior, Breast Cancer
Birmingham, Alabama, United States
View Trial Details